Beta Bionics, Inc. (BBNX)
NASDAQ: BBNX · Real-Time Price · USD
14.18
+0.23 (1.65%)
At close: May 12, 2025, 4:00 PM
14.75
+0.57 (4.02%)
After-hours: May 12, 2025, 6:24 PM EDT

Beta Bionics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22
Net Income
-70.96-54.76-44.1-64.75
Depreciation & Amortization
2.322.282.092.09
Other Amortization
---0.01
Loss (Gain) From Sale of Assets
0.020.020.010.04
Loss (Gain) From Sale of Investments
-2.95-2.91-0.75-
Stock-Based Compensation
7.836.385.666.1
Provision & Write-off of Bad Debts
0.050.070.05-
Other Operating Activities
21.3212.789.9-0.91
Change in Accounts Receivable
-2.76-7.62-4.49-
Change in Inventory
-11.65-11.44-1.19-
Change in Accounts Payable
1.011.520.72-0.08
Change in Unearned Revenue
2.392.460.34-0.18
Change in Other Net Operating Assets
-2.722.94-0.68-2.53
Operating Cash Flow
-56.1-48.27-32.45-60.21
Capital Expenditures
-3.32-3.4-0.4-0.77
Sale of Property, Plant & Equipment
-0.0500
Investment in Securities
-186.92-0.13-69.3-
Investing Cash Flow
-190.24-3.48-69.69-0.77
Issuance of Common Stock
211.220.10.030.39
Other Financing Activities
-4.15-4.15-11.41
Financing Cash Flow
266.7355.62101.0356.78
Net Cash Flow
20.383.87-1.11-4.2
Free Cash Flow
-59.43-51.67-32.85-60.98
Free Cash Flow Margin
-85.10%-79.34%-273.84%-34067.04%
Free Cash Flow Per Share
-4.74-8.12-6.19-12.20
Levered Free Cash Flow
--35.24-19.66-
Unlevered Free Cash Flow
--35.24-19.66-
Change in Net Working Capital
-12.234.6-
Updated Mar 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q